Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1963 1
1964 2
1965 2
1966 2
1967 1
1968 1
1969 3
1970 3
1971 3
1972 3
1975 1
1976 1
1977 2
1978 3
1980 1
1981 1
1983 3
1984 2
1985 3
1986 1
1987 3
1988 4
1989 3
1990 3
1991 5
1992 5
1993 5
1995 1
1997 2
1998 5
2000 2
2001 1
2002 3
2003 4
2004 9
2005 1
2006 4
2007 4
2008 3
2009 2
2010 3
2011 3
2012 6
2013 4
2014 6
2015 6
2016 3
2017 7
2018 5
2019 8
2020 4
2021 12
2022 10
2023 9
2024 11
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Adaptation of PCR-based library preparation for MGI platform for cancer mutation testing in clinical setting.
Shatalov PA, Raygorodskaya MP, Shinkarkina AP, Traspov AA, Murzaeva AV, Doroshenko YA, Leuhina IA, Mileyko VA, Ivanov MV, Grigoreva TV, Lebedeva AA, Veselovsky EM, Belyaeva LD, Belova EV, Kaprin AD, Shegai PV. Shatalov PA, et al. Among authors: belova ev. PLoS One. 2025 Jun 4;20(6):e0323685. doi: 10.1371/journal.pone.0323685. eCollection 2025. PLoS One. 2025. PMID: 40465654 Free PMC article.
The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy Response.
Lebedeva A, Taraskina A, Grigoreva T, Belova E, Kuznetsova O, Ivanilova D, Sergeeva A, Kavun A, Veselovsky E, Nikulin V, Aliyarova S, Belyaeva L, Tryakin A, Fedyanin M, Mileyko V, Ivanov M. Lebedeva A, et al. Among authors: belova e. Int J Mol Sci. 2025 Apr 5;26(7):3420. doi: 10.3390/ijms26073420. Int J Mol Sci. 2025. PMID: 40244273 Free PMC article.
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities.
Fiore D, Cappelli LV, Zhaoqi L, Kotlov N, Sorokina M, Phillip J, Zumbo P, Yoffe L, Ghione P, Wang A, Han X, Taylor A, Chiu W, Fragliasso V, Tabbo F, Zamponi N, Di Siervi N, Kayembe C, Medico G, Patel RP, Gaudiano M, Machiorlatti R, Astone G, Cacciapuoti MT, Zanetti G, Pignataro C, Eric RA, Patel S, Zammarchi F, Zanettini C, Queiroz L, Nikitina A, Kudryashova O, Karelin A, Nikitin D, Tychinin D, Postovalova E, Bagaev A, Svekolkin V, Belova E, Tikhonova K, Degryse S, Xu C, Novero D, Ponzoni M, Tiacci E, Falini B, Song J, Khodos I, De Stanchina E, Macari G, Cafforio L, Gardini S, Piva R, Medico E, Ng SY, Moskowitz A, Epstein Z, Intlekofer A, Ahmed D, Chan WC, Martin P, Ruan J, Bertoni F, Foà R, Brody JD, Weinstock DM, Osan J, Santambrogio L, Elemento O, Betel D, Tam W, Ruella M, Cerchietti L, Rabadan R, Horwitz S, Inghirami G. Fiore D, et al. Among authors: belova e. Cell Rep Med. 2025 Apr 15;6(4):102029. doi: 10.1016/j.xcrm.2025.102029. Epub 2025 Mar 26. Cell Rep Med. 2025. PMID: 40147445 Free PMC article.
Analytical and Clinical Validation of Solo-Test Driver: A Targeted Amplicon-Based NGS Test-System for FFPE and cfDNA Analysis in Clinical Oncology Setting.
Ivanov M, Lebedeva A, Belova E, Grigoreva T, Veselovsky E, Kavun A, Taraskina A, Kuznetsova O, Nikulin V, Belyaeva L, Kravchuk D, Lisitsa T, Barinov A, Pospekhova N, Aliyarova S, Khomenko E, Tryakin A, Demidova I, Stroganova A, Fedyanin M, Mileyko V. Ivanov M, et al. Among authors: belova e. J Clin Lab Anal. 2025 Mar;39(6):e70008. doi: 10.1002/jcla.70008. Epub 2025 Mar 8. J Clin Lab Anal. 2025. PMID: 40056420 Free PMC article.
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease.
Kravchuk D, Lebedeva A, Kuznetsova O, Kavun A, Taraskina A, Belova E, Grigoreva T, Veselovsky E, Mileyko V, Nikulin V, Nekrasova L, Tryakin A, Fedyanin M, Ivanov M. Kravchuk D, et al. Among authors: belova e. Front Immunol. 2025 Feb 5;16:1492296. doi: 10.3389/fimmu.2025.1492296. eCollection 2025. Front Immunol. 2025. PMID: 39975556 Free PMC article.
Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment.
Veselovsky E, Lebedeva A, Kuznetsova O, Kravchuk D, Belova E, Taraskina A, Grigoreva T, Kavun A, Yudina V, Belyaeva L, Nikulin V, Mileyko V, Tryakin A, Fedyanin M, Ivanov M. Veselovsky E, et al. Among authors: belova e. Sci Rep. 2024 Oct 8;14(1):23454. doi: 10.1038/s41598-024-73952-1. Sci Rep. 2024. PMID: 39379462 Free PMC article.
213 results